return to news
  1. Navin Fluorine zooms 15%, hitting all-time high on robust Q2 numbers; EBITDA jumps 129%

Market News

Navin Fluorine zooms 15%, hitting all-time high on robust Q2 numbers; EBITDA jumps 129%

Upstox

2 min read | Updated on October 31, 2025, 10:29 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Navin Fluorine: As per the company's financial statement, its consolidated net revenue from operations jumped 46.26% YoY to ₹758.42 crore, while its operating EBITDA advanced 129.32% YoY to ₹246.17 crore. Operating EBITDA margin zoomed an impressive 1,176 bps YoY to 32.46%.

Stock list

Buzzing stocks today, Oct 31

Profit Before Tax came in at ₹197.50 crore, up 157.33% YoY. | Image: Shutterstock

Navin Fluorine Q2: Shares of Navin Fluorine rallied as much as 15% to hit a record high of ₹5,728.60 apiece on the NSE in the early trade on Friday, October 31. The stock jumped after the company reported a robust set of numbers for the quarter ended September 30, 2025 (Q2 FY26).
Open FREE Demat Account within minutes!
Join now

As per the company’s financial statement, its consolidated net revenue from operations jumped 46.26% YoY to ₹758.42 crore, while its operating EBITDA advanced 129.32% YoY to ₹246.17 crore. Operating EBITDA margin zoomed an impressive 1,176 bps YoY to 32.46%.

The company's profit before tax (PBT) came in at ₹197.50 crore, up 157.33% YoY, while profit after tax was up 152.24% YoY to ₹148.37 crore.

Besides, the company said its board has approved capital expenditure of ₹236.50 crore for setting up an additional HFC capacity of up to 15K MTPA R32 equivalent quantity at the Surat unit of the company.

The company further mentioned that the total comprehensive income for the period came in at ₹147.76 crore, up 144.64% YoY.

Additionally, the board has approved funding of ₹75 crore for debottlenecking of the multipurpose plant facility at Dahej by the company’s wholly owned subsidiary, Navin Fluorine Advanced Sciences Limited.

Other key updates

The company announced an interim dividend of ₹6.50 per share of the face value of ₹2 each (i.e., 325% of the face value) for the financial year 2025-2026.

During the quarter ended September 30, 2025 , the fund raising committee at its meeting held on 11th July, 2025 approved the allotment of 16,02,564 equity shares of ₹2 each through qualified institutional placement (QIP) to the eligible qualified institutional buyers, at the issue price of ₹4,680.00 per equity share (including a premium of 4,678.00 per equity share), aggregating to approximately ₹750.00 crore.

Expenses incurred in relation to QIP have been adjusted from the Securities Premium Account. The funds raised by the company pursuant to QIP have been partially utilised as at and for the period ended September 30, 2025, and unutilised balances as at September 30, 2025, have been temporarily invested in accordance with the 'Use of Proceeds' mentioned in the placement document of QIP.

The company operates only in one Business Segment, i.e., 'Chemical Business', which constitutes a single reportable segment in accordance with the requirements of Ind AS I 08, ' Operating Segments'.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story